The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 30, 2025
Filed:
Apr. 27, 2021
Applicant:
Autotac Inc., Seoul, KR;
Inventors:
Yong Tae Kwon, Seoul, KR;
Hyun Tae Kim, Seoul, KR;
Jeong Eun Na, Gyeonggi-do, KR;
Yu Jin Seo, Gyeonggi-do, KR;
Chang Hoon Ji, Seoul, KR;
Ha Rim Choi, Seoul, KR;
Ji Eun Lee, Seoul, KR;
Ah Jung Heo, Gyeonggi-do, KR;
Assignee:
AUTOTAC INC., Seoul, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 311/49 (2006.01); C07C 235/16 (2006.01); C07C 237/42 (2006.01); C07C 243/36 (2006.01); C07C 243/38 (2006.01); C07C 311/39 (2006.01); C07C 317/28 (2006.01); C07C 317/36 (2006.01); C07D 207/12 (2006.01); C07D 209/08 (2006.01); C07D 209/30 (2006.01); C07D 209/34 (2006.01); C07D 209/42 (2006.01); C07D 209/44 (2006.01); C07D 211/54 (2006.01); C07D 231/18 (2006.01); C07D 231/56 (2006.01); C07D 277/36 (2006.01); C07D 295/135 (2006.01); C07D 307/68 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
C07C 311/49 (2013.01); C07C 235/16 (2013.01); C07C 237/42 (2013.01); C07C 243/36 (2013.01); C07C 243/38 (2013.01); C07C 311/39 (2013.01); C07C 317/28 (2013.01); C07C 317/36 (2013.01); C07D 207/12 (2013.01); C07D 209/08 (2013.01); C07D 209/30 (2013.01); C07D 209/34 (2013.01); C07D 209/42 (2013.01); C07D 209/44 (2013.01); C07D 211/54 (2013.01); C07D 231/18 (2013.01); C07D 231/56 (2013.01); C07D 277/36 (2013.01); C07D 295/135 (2013.01); C07D 307/68 (2013.01); C07D 471/04 (2013.01); C07C 2602/08 (2017.05);
Abstract
The present specification relates to a compound as a UBR box domain ligand. The present specification provides a small molecule compound that binds to the UBR box domain. Further, the present specification provides a composition for inhibiting UBR box domain substrate binding, including a ligand compound that binds to a UBR box domain, a pharmaceutical composition for treating UBR-related disease, and a use thereof.